Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001573886-26-000002
Filing Date
2026-03-04
Accepted
2026-03-04 16:26:24
Documents
1
Period of Report
2026-03-04

Document Format Files

Seq Description Document Type Size
1 form4-03042026_090318.html 4  
1 form4-03042026_090318.xml 4 14107
  Complete submission text file 0001573886-26-000002.txt   15546
Mailing Address C/O VENTYX BIOSCIENCES, INC. 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address
HULME ALLISON (Reporting) CIK: 0001573886 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 26721723

Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 7604076511
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)